INFLAMMATORY BOWEL DISEASES: CLINICAL CHARACTERISTICS AND MODERN TREATMENT METHODS

Authors

  • Matkarimova Gulasal Abdullayevna Physician and Gastroenterologist, Gastroenterology Department, Khorezm Regional Multidisciplinary Medical Center Author

Keywords:

inflammatory bowel disease, ulcerative colitis, Crohn's disease, intestinal inflammation, colonoscopy, fecal calprotectin, biologic therapy, immunomodulators, targeted therapy, clinical remission.

Abstract

Inflammatory bowel diseases (IBD), primarily ulcerative colitis and Crohn's disease, are chronic, relapsing inflammatory disorders of the gastrointestinal tract that can significantly affect patients' quality of life. The clinical manifestations of IBD vary depending on the localization, extent, and severity of inflammation and may include abdominal pain, diarrhea, rectal bleeding, weight loss, fatigue, fever, and extraintestinal manifestations. Early diagnosis and appropriate assessment of disease activity are essential for preventing complications and achieving sustained remission. Modern diagnosis is based on a combination of clinical assessment, laboratory investigations, fecal biomarkers, endoscopy with biopsy, and cross-sectional imaging. Treatment strategies have evolved substantially, with conventional anti-inflammatory drugs, corticosteroids, immunomodulators, biologic agents, and targeted small-molecule therapies being used according to disease severity and individual patient characteristics. The therapeutic goals have also shifted from symptomatic control toward sustained clinical and endoscopic remission, prevention of structural bowel damage, and improvement of long-term quality of life. This article reviews the main clinical characteristics, diagnostic approaches, and modern treatment methods for inflammatory bowel diseases.

References

1.Lichtenstein G.R., Loftus E.V., Isaacs K.L. et al. ACG Clinical Guideline: Management of Crohn's Disease in Adults. American Journal of Gastroenterology.

2.Rubin D.B., Ananthakrishnan A.N., Siegel C.A. et al. ACG Clinical Guideline: Ulcerative Colitis in Adults. American Journal of Gastroenterology.

3.Raine T., Bonovas S., Burisch J. et al. ECCO Guidelines on Therapeutics in Ulcerative Colitis. Journal of Crohn's and Colitis.

4.Maaser C., Sturm A., Vavricka S.R. et al. ECCO-ESGAR Diagnostic Assessment in IBD. Journal of Crohn's and Colitis.

5.Feagan B.G., Panaccione R., Sandborn W.J. et al. Advances in biologic and targeted therapies for inflammatory bowel disease. Gastroenterology.

6.Peyrin-Biroulet L., Sandborn W., Sands B.E. et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease.

7.Feuerstein J.D., Isaacs K.L., Schneider Y. et al. AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.

8.American Gastroenterological Association. Clinical practice guidelines for the management of Crohn's disease and ulcerative colitis.

9.Nazirov F.G., Babadjanov A.Kh. et al. Research on gastrointestinal and hepatobiliary diseases. Tashkent, Uzbekistan.

10.Babadjanov A.Kh. et al. Clinical and diagnostic aspects of gastrointestinal and hepatic disorders. Journal of Hepato-Gastroenterology Research, Uzbekistan.

Downloads

Published

2026-09-14